[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

[e-farmacos] Situacion de prolintano (cont.)


  • Subject: [e-farmacos] Situacion de prolintano (cont.)
  • From: "Carvajal, Alfonso" <carvajal@ife.uve.es>
  • Date: Tue, 9 Oct 2001 20:04:27 -0400 (EDT)

E-farmacos: Situacion de prolintano (cont.)
------------------------------------------------------

Estimado Mariano y demas colegas,

Una busqueda en la base de datos EURO-Medicines sobre
prolintano ha dado los resultados siguientes.


Saludos,

Alfonso Carvajal
Instituto de Farmacoepidemiologia
Valladolid
(Espanha)



Active ingredient: PROLINTANE
ATC code:  N06BX14 
Country: FRANCE 
Trade name: PROMOTIL
Strenght:  10 mg
 
Pharmaceutical form:  comprimes enrobes
Indications: Traitement des asthenies psychiques.
MK Holder:  Boerhinger Ing France
Status:  withdrawn from the market before 1999
No information about the reason for withdrawal.
 
Country:  BELGIUM
Trade name : CATORID
Strenght: 10 mg
Pharmaceutical form:  drag.
Pack size:  20x
Price:  129 BEF (3.20 euro)
Legal status:  Need of medical prescription
Reimbursement:  Not reimbursed
Indications:  Narcolepsie
Posology:  1-2 drags in the morning + 1 drag early in
the afternoon
MK Holder:  Boerhinger Ing.
Status:  Still Present on the market at beginning 2001
 
Pietro Folino-Gallo

Source data: EURO-Medicines database. A project funded
by the Commission of the European Communnities


[NOTA: Mensaje sin acentos ni caracteres especiales.]




[NOTA: Mensaje sin acentos ni caracteres especiales.]
























__________________________________________________
Do You Yahoo!?
Make a great connection at Yahoo! Personals.
http://personals.yahoo.com
-
Env�e el correo para la conferencia de `e-farmacos' a:
e-farmacos@usa.healthnet.org
Env�e las peticiones administrativas a:
majordomo@usa.healthnet.org
Para la ayuda adicional, env�e el correo a:
owner-e-farmacos@usa.healthnet.org